Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: from bench to bedside
Ho, A, Wei, G, Maneval, E.C, Esquibel, V, Berger, M.F, Haque, S, Patel, R, Walsh, C, Hornby, Z, Multani, P, Li, G, Drilon, A
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Abstract OT3-2-07: Phase I study of ARN-810, a novel selective estrogen receptor degrader, in post-menopausal women with locally advanced or metastatic estrogen receptor positive breast cancer
Mayer, IA, Bardia, A, Dickler, MN, Manning, HC, Mahmood, U, Ulaner, GA, Hager, JH, Rix, P, Zack, N, Maneval, EC, Chen, I, Baselga, J, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article